Survival benefit of dose escalation for higher risk patients

As discussed in a previous article, there is a seeming discrepancy between the findings of Kalbasi et al. and RTOG 0126, at least for intermediate-risk patients. … READ MORE …

Rotating shift work and risk for prostate cancer

There have been suggestions in the past that people who work shifts, cycling between day and night work, may be at higher risk for various cancers than people who do regular daytime work. … READ MORE …

Statins as agents to reduce risk for prostate cancer

In the past few years we have become used to seeing data from a range of studies suggesting that ongoing statin therapy is associated with both a lowered risk for diagnosis with prostate cancer and beneficial impact on the outcomes of treatment for prostate cancer once diagnosed. However, … READ MORE …

Understanding the new Apifiny test for prostate cancer risk

We have just come across the first patient we know of to be given an Apifiny test for risk of prostate cancer. He had an Apifiny score of 89 — but quite what that might mean seems to be a little unclear (as is why this particular patient was given the test, since he is 81 years of age but, as yet, we don’t know his PSA level). … READ MORE …

The impact of bicycling on PSA levels … and risk for prostate cancer

Over the years it has been suggested, on and off, that bicycling may have impact on a man’s PSA levels and therefore on his potential risk for diagnosis of prostate cancer. However, there has never been any real evidence of such impact. … READ MORE …

Does diagnosis/treatment for prostate cancer increase risk for colorectal cancer too?

A newly published study in the journal of Cancer Control has again suggested the possibility that men treated for prostate cancer may be at elevated risk for a secondary diagnosis of colorectal cancer by comparison with similar men never diagnosed with prostate cancer. … READ MORE …

The complexity of assessment of prostate cancer risk

A new study just published online in the journal Cancer Discovery has helped to clarify — or perhaps “clarify” is the wrong word — just how complex risk for prostate cancer really is. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,343 other followers